suppl fig. 1a the clinical protocol is shown schematically
TRANSCRIPT
Suppl Fig. 1a The clinical protocol is shown schematically.
Suppl Fig. 1b The CONSORT diagram of the study enrollment.
Screened for eligibility (n=19)
Excluded (n=5) Not meeting inclusion criteria (n=5) Declined to participate (n=0) Died prior to enrolment (n=0)
Enrolled (n=14)
Randomized to Arm 2 (n=7)
Removed from study prior to vaccination (n=1) - Developed active lung infection (n=1)
Received any vaccines (n=6) Recurred after 1 vaccination (n=1)
Included in analysis (n=5)
Received any vaccines (n=5) Recurred after 2 vaccinations (n=1)
Randomized to Arm 1 (n=7)
Removed from study prior to vaccination (n=2) - Disease progression during vaccine production (n=1) - Developed dermatomyositis (n=1)
Included in analysis (n=5)